Compare BTOC & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BTOC | ICCC |
|---|---|---|
| Founded | 2020 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 55.5M |
| IPO Year | 2023 | 1995 |
| Metric | BTOC | ICCC |
|---|---|---|
| Price | $0.27 | $6.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 628.0K | 12.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 65.33 |
| EPS | N/A | ★ 0.20 |
| Revenue | ★ $190,408,258.00 | $26,493,169.00 |
| Revenue This Year | $34.89 | N/A |
| Revenue Next Year | $14.53 | N/A |
| P/E Ratio | ★ N/A | $32.15 |
| Revenue Growth | 14.03 | ★ 51.64 |
| 52 Week Low | $0.25 | $4.32 |
| 52 Week High | $1.78 | $7.60 |
| Indicator | BTOC | ICCC |
|---|---|---|
| Relative Strength Index (RSI) | 25.77 | 51.84 |
| Support Level | N/A | $6.13 |
| Resistance Level | $0.43 | $6.87 |
| Average True Range (ATR) | 0.04 | 0.24 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 15.43 | 59.05 |
Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.